Jeffrey C. Pepe - 02 Sep 2022 Form 3 Insider Report for Silverback Therapeutics, Inc. (SPRY)

Reporting relationship: Interim CEO and GC
Issuer ticker: SPRY
Reported as of: 02 Sep 2022
Net transaction value: $0
SEC form: 3
Accepted by SEC: 08 Sep 2022, 17:04:48 UTC
Source filing: View source filing
Reporting owner signature: /s/ Jeffrey C. Pepe

Key filing fact

Jeffrey C. Pepe filed Form 3 for Silverback Therapeutics, Inc. (SPRY) on 08 Sep 2022.

Key facts

This page summarizes Jeffrey C. Pepe's Form 3 filing for Silverback Therapeutics, Inc. (SPRY).
0 reported transactions and 9 derivative rows are listed below.
Accepted by SEC: 08 Sep 2022, 17:04.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SPRY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 52,323
Date: 02 Sep 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SPRY holding Derivative

Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 02 Sep 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,407
Exercise price: $1.68
Footnotes: F1

SPRY holding Derivative

Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 02 Sep 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 22,401
Exercise price: $1.27
Footnotes: F2

SPRY holding Derivative

Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 02 Sep 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,619
Exercise price: $1.27
Footnotes: F3

SPRY holding Derivative

Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 02 Sep 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,268
Exercise price: $1.27
Footnotes: F4

SPRY holding Derivative

Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 02 Sep 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 26,932
Exercise price: $6.65
Footnotes: F5

SPRY holding Derivative

Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 02 Sep 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 102,039
Exercise price: $21.00
Footnotes: F6

SPRY holding Derivative

Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 02 Sep 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 45,000
Exercise price: $4.85
Footnotes: F7

SPRY holding Derivative

Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 02 Sep 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 28,500
Exercise price: $4.85
Footnotes: F8

SPRY holding Derivative

Stock option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 02 Sep 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 79,261
Exercise price: $3.15
Footnotes: F9

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

25% of the shares subject to the option vested on August 19, 2020, and the remaining shares will vest monthly thereafter over three years.

Footnote F2

25% of the shares subject to the option vested on March 4, 2021, and the remaining shares will vest monthly thereafter over three years.

Footnote F3

25% of the shares subject to the option vested on July 1, 2021, and the remaining shares will vest monthly thereafter over three years.

Footnote F4

The shares subject to the option will vest in equal monthly installments over the 48 months beginning on October 18, 2020.

Footnote F5

The shares subject to the option will vest in equal monthly installments over the 48 months beginning on October 22, 2020.

Footnote F6

The shares subject to the option will vest in equal monthly installments over the 48 months beginning on January 3, 2021.

Footnote F7

The shares subject to the option will vest in equal monthly installments over the 48 months beginning on March 1, 2022.

Footnote F8

25% of the shares subject to the option will vest on February 1, 2023, and the remaining shares will vest monthly thereafter over three years.

Footnote F9

The shares subject to the option will vest on May 2, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .